Related Experiment Video
Updated: Jul 18, 2026
17:13
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
Published on: April 28, 2013
SDF-1 expression is elevated in chronic human renal allograft rejection
U Hoffmann1, B Banas, B Krüger
1Klinik und Poliklinik für Innere Medizin II, University of Regensburg, Regensburg, Germany. ute.hoffmann@klinik.uni-regensburg.de
Clinical Transplantation
|November 15, 2006
Summary
This study investigated Stromal cell-Derived Factor-1 (SDF-1) in kidney transplant biopsies. SDF-1 was significantly elevated in chronic allograft nephropathy, suggesting its role in renal allograft rejection.
Area of Science:
- Nephrology
- Immunology
- Transplantation Biology
Background:
- The precise mechanisms of acute and chronic allograft rejection remain incompletely understood.
- Stromal cell-Derived Factor-1 (SDF-1) has been implicated in various transplant rejections, but its role in renal transplantation is largely unexplored.
Purpose of the Study:
- To investigate the potential role of SDF-1 in human renal allograft rejection.
- To evaluate SDF-1 expression levels in renal allograft biopsies across different Banff classifications.
Main Methods:
- Immunohistochemistry was used to localize SDF-1 expression.
- Analysis included 190 formalin-fixed, paraffin-embedded renal allograft biopsies.
- Biopsies were categorized based on Banff 97 classification, including normal morphology, acute interstitial rejection, acute vascular rejection, chronic allograft nephropathy (CAN), and other lesions.
Main Results:
- SDF-1 expression was significantly upregulated in renal allograft biopsies from patients with chronic allograft nephropathy (CAN).
- Elevated SDF-1 was observed in interstitial infiltrates and arterial neointimal cells in CAN biopsies.
- This is the first study to report SDF-1's involvement in human renal allograft rejection.
Conclusions:
- The findings demonstrate an upregulation of SDF-1 in human renal allograft biopsies associated with CAN.
- Further research is required to elucidate whether SDF-1 exhibits pro-inflammatory or protective effects in this context.
Related Concept Videos
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...